Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Phenylephrine/ketorolac
Другие языки:

    Phenylephrine/ketorolac

    Подписчиков: 0, рейтинг: 0

    Phenylephrine/ketorolac
    Combination of
    Phenylephrine Alpha-1 adrenergic receptor agonist
    Ketorolac Nonsteroidal anti-inflammatory
    Clinical data
    Trade names Omidria
    AHFS/Drugs.com Monograph
    License data
    Routes of
    administration
    Intraocular
    ATC code
    Legal status
    Legal status
    • US: ℞-only
    • EU: Rx-only
    • In general: ℞ (Prescription only)
    Identifiers
    KEGG

    Phenylephrine/ketorolac, sold under the brand name Omidria, is a combination drug used during cataract surgery or intraocular lens replacement to prevent intraoperative miosis and to reduce postoperative pain. It contains phenylephrine and ketorolac.

    Phenylephrine/ketorolac was approved for medical use in the United States in May 2014, and in the European Union in July 2015.

    External links



    Новое сообщение